Abbott Laboratories Earnings
The next earnings date for Abbott Laboratories is October 14, 2026.
They are scheduled to announce earnings before the market opens that day.
Analyst Estimates of Abbott Laboratories Earnings
| 10/14/2026 | $1.42 |
What is an Earnings Date
An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.
Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.
Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.
Abbott Laboratories Earnings: Historical
| 07/16/2026 | Before Market | $1.31 | 2.34% |
| 04/16/2026 | Before Market | $1.15 | 0.00% |
| 01/22/2026 | Before Market | $1.50 | 0.67% |
| 10/15/2025 | Before Market | $1.30 | 0.00% |
| 07/17/2025 | Before Market | $1.26 | 0.00% |
| 04/16/2025 | Before Market | $1.09 | 1.87% |
| 01/22/2025 | Before Market | $1.34 | 0.00% |
| 10/16/2024 | Before Market | $1.21 | 0.83% |
| 07/18/2024 | Before Market | $1.14 | 3.64% |
| 04/17/2024 | Before Market | $0.98 | 3.16% |
More About Abbott Laboratories
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices. The company was formerly known as Abbott Alkaloidal Company and changed its name to Abbott Laboratories in 1915. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.
“Abbott Laboratories Earnings” Can Refer to the Abbott Laboratories Earnings Date
Some people say “Abbott Laboratories earnings” as a shortform way to refer to the earnings date.
For example, someone might say, “I plan to hold my Abbott Laboratories position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.
Owning Abbott Laboratories Stock on the Earnings Date
If you own Abbott Laboratories stock (ABT) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.
A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Abbott Laboratories might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.
There is often a big audience of investors involved with trading Abbott Laboratories shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.
These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.
Owning Abbott Laboratories Options on the Earnings Date
If you own Abbott Laboratories options on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.
In addition, the extrinsic values of Abbott Laboratories options that overlap earnings dates are often higher than other days of the year. In other words, the premiums you pay to own Abbott Laboratories options are typically higher during that period. In particular, they are frequently higher immediately before earnings and on the day they’re announced.
This makes sense considering that prices are often more volatile on earnings dates for Abbott Laboratories. That potential volatility is a key factor that affects the premium cost of owning options.
Once the earnings announcement is done and the anticipated price volatility has gone down, the extrinsic values of Abbott Laboratories options often go down. This is sometimes referred to as volatility crush.
Learning More Abbott Laboratories Earnings
You can contact us any time if you would like to ask questions about Abbott Laboratories earnings or anything else related to the stock market.